Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study

Annals of Surgery

Volumn 226, Issue 6, 1997, Pages 725-735

  De Mendes Almeida, José C ^b   Chaves, Paula ^b   Dias Pereira, A ^b   Altorki, Nasser K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTOCYTOCHEMISTRY; HUMANS; MUCOUS MEMBRANE; PHENOTYPE; SUCRASE-ISOMALTASE COMPLEX; TUMOR MARKERS, BIOLOGICAL;

EID: 0344906093     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199712000-00009     Document Type: Article

References (45)

1. Blomjous JG, Hop WC, Langenhorst BL, et al. Adenocarcinoma of the gastric cardia. Recurrence and survival after resection. Cancer 1992; 70:569-574.
2. Antonioli DA, Goldman H. Changes in the location and type of gastric adenocarcinoma. Cancer 1982; 50:775-781.
3. Paterson IM, Easton DF, Corbishely CM, Gazet JC. Changing distribution of adenocarcinoma of the stomach. Br J Surg 1987; 74:481- 482.
4. Sons HU, Borchard F. Cancer of the distal esophagus and cardia: incidence, tumorous infiltration, and metastatic spread. Ann Surg 1986; 203:188-195.
5. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-1289.
6. Ferguson MK, Little AG, Skinner DB. Barrett's esophagus. Advances in Surgery 1988; 21:127-155.
7. Duhaylongsod FG, Wolfe WG. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 1991; 102:36-41.
8. DeMeester TR, Attwood SE, Smyrk TC, et al. Surgical therapy in Barrett's esophagus. Ann Surg 1990; 212:528-540.
9. Li H, Walsh TN, Hennessy TP. Carcinoma arising in Barrett's esophagus. Surg Gynecol Obstet 1992; 175:167-172.
10. Streitz JM Jr, Ellis FH Jr, Gibb SP, et al. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg 1991; 213:122-125.
11. Clark GW, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994; 129:609- 614.
12. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population- based clinical and autopsy findings [see comments]. Gastroenterology 1990; 99:918-922.
13. Dias Pereira A, Suspiro A, Chaves P, et al. Esófago de Barrett - contributo para a definiçao dos critérios de diagnóstico [abstract]. J Port Gastrent 1995; 2 suppl.4.
14. Zeroogian JM, Spechler SJ, Antonioli DA, et al. The high prevalence of short-segment Barrett's esophagus [abstract]. Digestive Disease Week 1994; A362.
15. Haggitt RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978; 70:1-5.
16. Thompson JJ, Zeinsser KR, Enterline HT. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 1983; 14:42-60.
17. Osborn M, Mazzoleni G, Santini D, et al. Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas. Virchows Arch (A) 1988; 413:303-312.
18. Zweibaum A, Hauri H-P, Sterchi E, et al. Immunohistological evidence, obtained with monoclonal antibodies, of small intestinal brush border hydrolases in human colon cancers and foetal colons. Int J Cancer 1984; 34:591-598.
19. Wiltz O, O'Hara CJ, Steele Jr GD, Mercurio AM. Expression of enzymatically active Sucrase-isomaltase is a ubiquitous property of colon adenocarcinomas. Gastroenterology 1991; 100:1266-1278.
20. Wiltz O, O'Hara CJ, Steele Jr. GD, Mercurio AM. Sucrase-isomaltase: a marker associated with the progression of adenomatous polyps to adenocarcinomas. Surgery 1990; 108:269-276.
21. Quaroni A, Weiser MM, Lee S, Amodeo D. Expression of developmentally regulated crypt cell antigens in human and rat intestinal tumors. JNCI 1986; 77:405-411.
22. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105:40-50.
23. Wu GD, Beer DG, Moore JH, et al. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma. Gastroenterology 1993; 105:837-844.
24. Mendes de Almeida JC, Rajasekaran AK, Godwin T, et al. Barrett's esophagus and adenocarcinoma of the esophagus and cardia ubiquitously express sucrase-isomaltase and crypt cell antigen. Diseases Esoph 1996; 9:191-197.
25. Altorki NK, Sunagawa M, Little AG, Skinner DB. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991; 61:97- 99.
26. Holscher AH, Siewert JR, Bottcher K, et al. Surgical classification for adenocarcinomas of the gastroesophageal junction. In Siewert JR, Holscher AH, eds. Diseases of the Esophagus. Berlin: Springer- Verlag, 1988:571-578.
27. Quaroni A. Crypt cell antigen expression in human colon tumor cell lines: analysis with a panel of monoclonal antibodies to Caco- 2 luminal membrane components. JNCI 1986; 76:571-585.
28. Quaroni A, Isselbacher KJ. Study of intestinal cell differentiation with monoclonal antibodies to intestinal cell surface components. Dev Biol 1985; 111:267-279.
29. Quaroni A. Fetal characteristics of small intestinal crypt cells. Proc Natl Acad Sci 1986; 83:1723-1727.
30. Gorvel JP, Ferrero A, Chambraud L, et al Expression of sucraseisomaltase and dipeptidylpetidase IV in human small intestine and colon. Gastroenterology 1991; 101:618-625.
31. Hauri H-P, Sterchi EE, Bienz D, et al. Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells. J Cell Biol 1985; 101:838-851.
32. Campbell MJ, Machin D. Medical Statistics: A Commonsense Approach. Chichester: John Wiley & Sons, 1993.
33. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus: comparison of benign and malignant cases. Ann Surg 1983; 198:554-566.
34. Differentiated cells and the maintenance of tissues. In Alberts B, Bray D, Lewis J, et al., eds. Molecular Biology of the Cell. New York: Garland Publishing. 1989; 951-1000.
35. Pera M, Trastek VF, Pairolero PC, et al. Barrett's disease: pathophysiology of metaplasia and adenocarcinoma. Ann Thorac Surg 1993; 56:1191-1197.
36. Streitz JM Jr, Williamson WA, Ellis FH Jr. Current concepts concerning the nature and treatment of Barrett's esophagus and its complications [see comments] [review]. Ann Thorac Surg 1992; 54:586-591.
37. Neshat K, Sanchez CA, Galipeau PC, et al. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 1994; 106:1589-1595.
38. Menke-Pluymers MB, Mulder AH, Hop WC, et al. Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut 1994; 35;1348-1351.
39. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
40. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-816.
41. Jankowski J. McMenemin R, Yu C, Hopwood D, Wormsley KG. Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression. Gut 1992; 33:587-591.
42. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19:166-178.
43. Rusch VW, Levine DS, Haggitt R, Reid BJ. The management of high-grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 1994; 74:1225-1229.
44. Gossner W. Pathology of adenocarcinoma of the esophagus and gastroesophageal junction. In Holscher AH, Siewert JR, eds. Diseases of the Esophagus. Berlin: Springer-Verlag, 1988:39-44.
45. Bolognese A, Chirletti P, Sammartino P, et al. Surgical treatment of carcinoma of the gastroesophageal junction: an analysis of 215 cases, In Holscher AH, Siewert JR, eds. Diseases of the Esophagus. Berlin: Springer-Verlag, 1988:582-585.